Methods useful in endotoxin prophylaxis and therapy
AssigneeThe Rogosin Institute
InventorsDaniel M. Levine, Thomas S. Parker, Albert L. Rubin
Life of this patent
Estimating the term…
Abstract
Treatment and prophylaxis of endotoxin caused toxicity is disclosed. This is accomplished by administering a lipid into which the endotoxin of concern is associated, preferably together with a peptide which is not an apolipoprotein. Preferably, the two components are administered in the form of a reconstituted particle, although this is by no means required.
Claims7
Method for alleviating endotoxin caused toxicity in a subject comprising administering to a subject in need thereof an amount of (i) a peptide consisting of the amino acid sequence set forth in SEQ ID NO;
- 1 and (ii) a phosphatidylcholine, wherein (i) and (ii) are present in the form of an HDL like particle with which said endotoxin associates, in an amount sufficient to alleviate said toxicity.
Method for alleviating endotoxin caused toxicity in a subject comprising administering to a subject in need thereof, separate and consecutive administrations of (i) a peptide consisting of the amino acid sequence f SEQ ID NO:
- 1 and (ii) a phosphatidylcholine with which said endotoxin associates, wherein (i) and (ii) are administered in an amount of each sufficient to alleviate said toxicity.
Method for reducing risk of endotoxin caused toxicity in a subject comprising administering to a subject who is to be subjected to exposure to an endotoxin an amount of (i) a peptide consisting of the amino acid sequence set forth in SEQ ID NO 1 and (ii) a phosphatidylcholine with which said endotoxin associates, wherein (i) and (ii) are present in the form of an HDL like particle, in an amount sufficient to reduce risk of endotoxin caused toxicity.
Dependencies are inferred from the claim text.